Evidence map›Paper›PMID 36688095›Full record

ArticleArthroplasty today2023

Ceramic Coatings Confer No Survivorship Advantages in Total Knee Arthroplasty-A Single-Center Series of 1641 Knees.

Christopher J Lodge, Hosam E Matar, Reshid Berber, Philip J Radford, Benjamin V Bloch

Open access · goldAbstract read
In one paragraph

Article in Arthroplasty today, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Current developments in orthopaedic implant technology.Journal of orthopaedic surgery and research · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christopher J LodgeNottingham University Hospitals NHS Trust, Nottingham Elective Orthopaedic Services, Nottingham, UK.
Hosam E MatarNottingham University Hospitals NHS Trust, Nottingham Elective Orthopaedic Services, Nottingham, UK.
Reshid BerberNottingham University Hospitals NHS Trust, Nottingham Elective Orthopaedic Services, Nottingham, UK.
Philip J RadfordNottingham University Hospitals NHS Trust, Nottingham Elective Orthopaedic Services, Nottingham, UK.
Benjamin V BlochNottingham University Hospitals NHS Trust, Nottingham Elective Orthopaedic Services, Nottingham, UK.
Nottingham University Hospitals NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ceramic coatings in total knee arthroplasty have been introduced with the aim of reducing wear and consequently improving implant survivorship. We studied both cobalt-chrome-molybdenum (CoCrMo) and ceramic-coated components of the same implant design from a single center to identify if the ceramic coating conferred any benefit. Methods: We identified 1641 Columbus total knee arthroplasties (Aesculap AG, Tüttlingen, Germany) from a prospectively collected arthroplasty database. Of the 1641, 983 were traditional CoCrMo, and 659 had the Columbus AS ceramic coating. Patients were followed up until death or revision of any component of the implant. Results: There was no significant difference in implant survivorship using any component revision as the endpoint between the CoCrMo femur and the ceramic-coated femur at a mean of 9.2 years in follow-up for the CoCrMo group and 5 years for the ceramic-coated group (37 vs 14; Conclusions: At midterm follow-up, there was no benefit in terms of implant survivorship in using a ceramic coating.

Indexed as

Ceramic coated TKAImplant survivorshipSurface coatingTotal knee arthroplasty

Identifiers

PMID36688095
PMCPMC9851869
OpenAlexW4316664840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.